Exciting results obtained by our decision-support platform - we presented our research at #AACR2018 and showed other cancer researchers our discovery of how CureMatch is revolutionizing Cancer treatment today. This study highlights the possible benefits of an evidence-based selection of personalized therapy options in terms of patient response, and validates the data mining methods and optimized algorithms used by the CureMatch PreciGENE® therapeutic decision-support system.
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.